Literature DB >> 28005169

Paroxysmal atrial fibrillation during intracoronary acetylcholine provocation test.

Yuichi Saito1, Hideki Kitahara2, Toshihiro Shoji2, Satoshi Tokimasa2, Takashi Nakayama2, Kazumasa Sugimoto2, Yoshihide Fujimoto2, Yoshio Kobayashi2.   

Abstract

Intracoronary acetylcholine (ACh) provocation test is useful to diagnose vasospastic angina. However, paroxysmal atrial fibrillation (AF) often occurs during intracoronary ACh provocation test, leading to disabling symptoms. The aim of this study was to investigate the incidence and predictors of paroxysmal AF during the test. A total of 377 patients without persistent AF who underwent intracoronary ACh provocation test were included. Paroxysmal AF during ACh provocation test was defined as documented AF on electrocardiogram during the procedure. There were 31 patients (8%) with paroxysmal AF during the test. Of these, 11 (35%) required antiarrhythmic drugs, but none received electrical cardioversion. All of them recovered sinus rhythm within 48 h. At procedure, paroxysmal AF occurred mostly during provocation for the right coronary artery (RCA) rather than for the left coronary artery (LCA) (90 vs. 10%). Multivariate logistic regression analysis demonstrated that a history of paroxysmal AF (OR 4.38 CI 1.42-13.51, p = 0.01) and body mass index (OR 0.88 CI 0.78-0.99, p = 0.03) were independent predictors for occurrence of paroxysmal AF during intracoronary ACh provocation test. In conclusions, paroxysmal AF mostly occurs during ACh provocation test for the RCA, especially in patients with a history of paroxysmal AF and lower body mass index. It may be better to initially administer intracoronary ACh in the LCA when the provocation test is performed.

Entities:  

Keywords:  Acetylcholine provocation test; Paroxysmal atrial fibrillation; Vasospastic angina

Mesh:

Substances:

Year:  2016        PMID: 28005169     DOI: 10.1007/s00380-016-0939-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  32 in total

1.  Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-01       Impact factor: 2.037

2.  Intracoronary Acetylcholine Provocation Testing - Omission of the 20-µg Dose Is Feasible in Patients Without Coronary Artery Spasm in the Other Coronary Artery.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Circ J       Date:  2016-06-28       Impact factor: 2.993

Review 3.  Mathematical approaches to understanding and imaging atrial fibrillation: significance for mechanisms and management.

Authors:  Natalia A Trayanova
Journal:  Circ Res       Date:  2014-04-25       Impact factor: 17.367

Review 4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

5.  Differential characterization of blood flow, velocity, and vascular resistance between proximal and distal normal epicardial human coronary arteries: analysis by intracoronary Doppler spectral flow velocity.

Authors:  E O Ofili; M J Kern; J A St Vrain; T J Donohue; R Bach; B al-Joundi; F V Aguirre; R Castello; A J Labovitz
Journal:  Am Heart J       Date:  1995-07       Impact factor: 4.749

6.  Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm.

Authors:  K Okumura; H Yasue; K Matsuyama; K Goto; H Miyagi; H Ogawa; K Matsuyama
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

7.  3-year follow-up of patients with coronary artery spasm as cause of acute coronary syndrome: the CASPAR (coronary artery spasm in patients with acute coronary syndrome) study follow-up.

Authors:  Peter Ong; Anastasios Athanasiadis; Gabor Borgulya; Matthias Voehringer; Udo Sechtem
Journal:  J Am Coll Cardiol       Date:  2011-01-11       Impact factor: 24.094

8.  Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries.

Authors:  Peter Ong; Anastasios Athanasiadis; Gabor Borgulya; Ismail Vokshi; Rachel Bastiaenen; Sebastian Kubik; Stephan Hill; Tim Schäufele; Heiko Mahrholdt; Juan Carlos Kaski; Udo Sechtem
Journal:  Circulation       Date:  2014-02-26       Impact factor: 29.690

9.  Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium.

Authors:  R B Schuessler; T M Grayson; B I Bromberg; J L Cox; J P Boineau
Journal:  Circ Res       Date:  1992-11       Impact factor: 17.367

10.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

View more
  2 in total

1.  Feasibility and safety of outpatient cardiac catheterization with intracoronary acetylcholine provocation test.

Authors:  Yuichi Saito; Hideki Kitahara; Toshihiro Shoji; Satoshi Tokimasa; Takashi Nakayama; Kazumasa Sugimoto; Yoshihide Fujimoto; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-02-12       Impact factor: 2.037

Review 2.  Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When.

Authors:  Thomas J Ford; Peter Ong; Udo Sechtem; John Beltrame; Paolo G Camici; Filippo Crea; Juan-Carlos Kaski; C Noel Bairey Merz; Carl J Pepine; Hiroaki Shimokawa; Colin Berry
Journal:  JACC Cardiovasc Interv       Date:  2020-08-24       Impact factor: 11.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.